Efficacy and Safety of Pyrotinib Versus T-DM1 in HER2+ Metastatic Breast Cancer Patients Pre-Treated With Trastuzumab and a Taxane: A Bayesian Network Meta-Analysis

Efficacy and Safety of Pyrotinib Versus T-DM1 in HER2+ Metastatic Breast Cancer Patients Pre-Treated With Trastuzumab and a Taxane: A Bayesian Network Meta-Analysis

PurposeTo compare the efficacy and safety between pyrotinib (Pyr) and trastuzumab emtansine (T-DM1) in pre-treated human epidermal growth factor receptor 2-positive (HER2+) metastatic breast cancer (MBC) patients.MethodsA comprehensive literature search of the PubMed, EMBASE, and Web of Science was...

Full description

Bibliographic Details
Main Authors: Hao Liao, Wenfa Huang, Yaxin Liu, Wendi Pei, Huiping Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-05-01
Series:Frontiers in Oncology
Subjects:
network meta-analysis
trastuzumab emtansine
pyrotinib
human epidermal growth factor
metastatic breast cancer
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.608781/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.608781/full

Similar Items